The Epidemiology of Huntington’s Disease in Iceland
The prevalence and incidence of HD in Iceland have increased compared to the 2007 study but remain lower than in other European populations. Results showed a lower number of CAG repeats in the Icelandic HD population, potentially explaining the higher age at symptom onset and death compared to global averages. .
Authors
- Vigdís Stefánsdóttir (ORCID: https://orcid.org/0000-0003-4451-3126)
- Jakob Jönsson (ORCID: https://orcid.org/0000-0003-3908-5841)
- Ólafur Sveinsson (ORCID: https://orcid.org/0000-0002-4507-2935)
- S. Briem
Institutions
- Reykjavík University (IS)
- University of Iceland (IS)
- National University Hospital of Iceland (IS)
Publication Details
- Journal
- European Neurology
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1159/000546150
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00